<!doctype html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<TITLE>Preliminary Program</TITLE>

<style>

BODY {
   MARGIN-TOP: 15pt;
   MARGIN-LEFT: 15pt;
   MARGIN-RIGHT: 15pt;
   MARGIN-BOTTOM: 15pt;
   FONT-SIZE: 10pt;
   FONT-FAMILY: "Times New Roman";
   BACKGROUND-COLOR: #ffffff;
   COLOR: #000000;
}

P {
   FONT-SIZE: 10pt;
}

TD {
   FONT-SIZE: 10pt;
}

TH {
   FONT-SIZE: 10pt;
}


A {
   COLOR: #32426c;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
}
A:visited {
   COLOR: #32426c;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
}
A:active {
   COLOR: #32426c;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
   TEXT-DECORATION: none
}
A:hover {
   COLOR: #32426c;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
   TEXT-DECORATION: underline
}
H4 {
   FONT-SIZE: 10pt;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
}

H3 {
   FONT-SIZE: 11pt;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
}

H2 {
   FONT-SIZE: 12pt;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
}

H1 {
   FONT-SIZE: 14pt;
   FONT-FAMILY: Arial, Helvetica, sans-serif;
}

</style>

<p>

<h4>Design and development of a transdermal drug delivery system</h4>

<em>Beatriz Olalde,&nbsp;Manuel Montejo,&nbsp;Thierry Keller,&nbsp;Lara Diaz de Grenu,&nbsp;Goran Bijelic</em><br>
TECNALIA

<p>

<hr>


<h4>Abstract</h4>

<blockquote>
    <p>Currently the transdermal route has become one of the most successful and innovative focus in drug delivery, with around 40% of the drug candidates being under clinical evaluation related to transdermal or dermal systems. In the development of new transdermal drug delivery devices the main challenge is to obtain controlled, predictable and reproducible release of drugs into the blood stream of the patient. One of the possible techniques used for transdermal delivery is iontophoresis. Based on these principles a device for the active and controlled delivery of biologically active substances and agents has been designed. The solution is a disposable patch comprising a programmable discharge element, iontophoretic electrodes and active substance loaded reservoir. The control method designed for the device achieves more reproducible drug delivery profiles offering smaller inter and intra subject variations.</p> </p>
</blockquote>




<hr>

<p>
</body>
</html>